Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Submitted by
admin
on February 3, 2012 - 10:00am
Source:
Yahoo/Fly on the Wall
News Tags:
Xgeva
Amgen
prostate cancer
advisory panels
Headline:
Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Do Not Allow Advertisers to Use My Personal information
